Docoh
Loading...

SNN Smith & Nephew

Filed: 17 Nov 21, 9:52am
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
Report of Foreign Private Issuer
 
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
 
November 17, 2021 
 
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant's name)
 
Building 5, Croxley Park,
Hatters Lane, Watford, Hertfordshire, WD18 8YE,
England
 
(Address of registrant's principal executive offices)
 
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]
 
Form 20-F X                Form 40-F
    ---                               ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]
 
Yes                        No X
---                         ---
 
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]
 
Yes                      No X
---                         ---
[Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
 
Yes                  No X
---                   ---
 
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
 
 
 
SMITH & NEPHEW PLC
 
17 November 2021
 
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.
 
On 16 November 2021, Smith+Nephew was notified that the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested under the Smith & Nephew Global Share Plan 2010.
 
1.       FINAL VESTING ON 13 NOVEMBER 2021 OF A CONDITIONAL SHARE AWARD MADE UNDER THE GLOBAL SHARE PLAN 2010:
 
The award was granted under the Global Share Plan 2010 on 13 November 2018. One third of the shares vested on 13 November 2019, a further third vested on 13 November 2020 and the final third vested on 13 November 2021. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.
 
The following relates to individuals included in the below notification:
 
Reason for the notification
Initial notification /AmendmentInitial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
NameSmith & Nephew plc
LEI213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
 
Smith & Nephew plc ordinary shares of USD 0.20 each
 
Identification codeISIN: GB0009223206
Nature of the transactionFinal vesting of a Conditional Share Award granted on 13 November 2018 under the Smith & Nephew Global Share Plan 2010.
Date of Transaction2021 - 11 - 15
Place of TransactionLondon Stock Exchange (XLON)
 
Name
(Position)
 
Director / PDMR
 
Price
 
Volume
 
Aggregated information
 
Total Ordinary Share Holding following the transaction *
Total Ordinary Share Holding as a % of the Company's ISC following the transaction *
 
Skip Kiil
(President Orthopaedics)
 
PDMR
£13.105
 
 
18,351 (of which 7,247 were sold and 11,104 retained)
 
N/A Single Transaction
 
23,306.12693 ordinary shares
 
0.00263%
 
 
 
* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.
 
 
2.       SKIP KIIL - SALE OF ORDINARY SHARES
 
Reason for the notification
Initial notification /AmendmentInitial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
NameSmith & Nephew plc
LEI213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
 
Smith & Nephew plc ordinary shares of USD 0.20 each
 
Identification codeISIN: GB0009223206
Nature of the transactionSale of ordinary shares.
Date of Transaction2021 - 11 - 16
Place of TransactionLondon Stock Exchange (XLON)
 
Name (Position)
 
Director / PDMR
 
Price (£)
 
Volume
 
Aggregated information
 
Total Ordinary Share Holding following the transaction *
Total Ordinary Share Holding as a % of the Company's ISC following the transaction *
 
Skip Kiil
(President Orthopaedics)
 
PDMR
 
13.12461223,306
N/A Single Transaction
 
0.12693 ordinary shares
 
0.00000%
 
 
* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.
 
Susan Swabey  
Company Secretary
Smith & Nephew plc
 
Tel:  +44 (0)1923 477410
 
 
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
Smith & Nephew Plc
(Registrant)
 
 
Date: November 17, 2021
 
 
By: /s/ Susan Swabey
-----------------
                                                                                                                              Susan Swabey
                                                                                                                      Company Secretary